Search
for

    Sort by

    Research 31–60 of 1000+

    1. 테스토스테론으로 유도된 전립선 비대증에 대한 Sapium rotundifolium Hemsl. 추출물의 효과 KMOU Repository (Korea Maritime and Ocean University) · 2019
    2. The effects of lovastatin on conventional medical treatment of lower urinary tract symptoms with finasteride International Braz J Urol · 2008 · 24 citations
    3. Risk of Depression after 5 Alpha Reductase Inhibitor Medication: Meta-Analysis The World Journal of Men's Health · 2019 · 4 citations
    4. Safety and efficacy of advanced and targeted acid α-glucosidase (AT-GAA) (ATB200/AT2221) in ERT-switch nonambulatory patients with Pompe disease: preliminary results from the ATB200-02 trial Molecular genetics and metabolism · 2019 · 3 citations
    5. Why would men use finasteride in 2005? Current Prostate Reports · 2005
    6. The Role of Non-Aromatizable Testosterone Metabolite in Metabolic Pathways Physiological Research · 2011 · 21 citations
    7. 5-Alpha-Reductase Inhibitors and Combination Therapy Urologic Clinics of North America · 2016 · 15 citations
    8. 1747 PREDICTION OF BLADDER PROSTATIC OBSTRUCTION: DEVELOPMENT OF A SIMPLIFIED CLINICAL NOMOGRAM The Journal of Urology · 2013
    9. Continued improvement in pressure-flow parameters in men receiving finasteride for 2 years Urology · 1999 · 27 citations
    10. Editorial Comment 2021
    11. Alpha Blocker and 5-Alpha Reductase Inhibitor Prescribing Habits among Urologists and Primary Care Physicians Urology Practice · 2019
    12. Finasteride-Induced Gynecomastia in a 62-Year-Old Man The American Journal of the Medical Sciences · 1995 · 15 citations
    13. An Unusual Presentation of Massive Asymptomatic Urinary Retention in a 63-Year-Old Male With Iron Deficiency Anaemia Cureus · 2025
    14. Re: Androgenetic Alopecia as an Early Marker of Benign Prostatic Hyperplasia The Journal of Urology · 2012 · 5 citations
    15. Biochemical and Histopathological evaluation of prostatic tissue under effect of Pterostilbene in benign prostatic hyperplasia rat model Al Mustansiriyah Journal of Pharmaceutical Sciences · 2023 · 2 citations
    16. Oral administration of berberine represses macrophage activation-associated benign prostatic hyperplasia: a pivotal involvement of the NF-κB Aging · 2021 · 8 citations
    17. Benign Prostatic Hyperplasia and Sexual Dysfunction: Review of the Impact of New Medical and Surgical Therapies on Sexual Health Current Urology Reports · 2025 · 4 citations
    18. Efficacy and Safety of Thermobalancing Therapy in Men with Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia was Confirmed by Clinical Trial ARC Journal of Urology · 2016 · 1 citations
    19. Effect of the ethanol extract of Syzygium aromaticum (clove) leaves on the lipid profile and body weight in testosterone-induced benign prostatic hyperplasia rats Global Translational Medicine · 2026
    20. Effect of dutasteride on the detection of prostate cancer in men with benign prostatic hyperplasia. The Journal of Urology · 2005
    21. Neuropsychological Assessment in Elderly Men with Benign Prostatic Hyperplasia Treated with Dutasteride Clinical Drug Investigation · 2018 · 20 citations
    22. Male breast cancer after finasteride therapy for benign prostate hyperplasia Urological Science · 2013 · 1 citations
    23. What do we know about phytotherapy of benign prostatic hyperplasia? Life Sciences · 2015 · 67 citations
    24. Efficacy and Side Effects of Drugs Commonly Used for the Treatment of Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia Frontiers in Pharmacology · 2020 · 35 citations
    25. Is COVID-19 a risk factor for progression of benign prostatic hyperplasia and exacerbation of its related symptoms?: a systematic review Prostate Cancer and Prostatic Diseases · 2021 · 21 citations
    26. Long-term dutasteride therapy in men with benign prostatic hyperplasia alters glucose and lipid profiles and increases severity of erectile dysfunction Hormone Molecular Biology and Clinical Investigation · 2017 · 20 citations
    27. Finasteride, not tamsulosin, increases severity of erectile dysfunction and decreases testosterone levels in men with benign prostatic hyperplasia Hormone Molecular Biology and Clinical Investigation · 2015 · 20 citations
    28. Efficacy and safety of 5 alpha-reductase inhibitor monotherapy in patients with benign prostatic hyperplasia: A meta-analysis PLOS ONE · 2018 · 19 citations
    29. A herbal formula, comprising Panax ginseng and bee-pollen, inhibits development of testosterone-induced benign prostatic hyperplasia in male Wistar rats Saudi Journal of Biological Sciences · 2015 · 8 citations
    30. Hydroxychloroquine modulates the progression of experimentally induced benign prostatic hyperplasia in rats via targeting EGFR/ERK/STAT3 and AR/FOXO1/TRAIL pathways: computational and in vivo studies Scientific Reports · 2025 · 1 citations